Cleared Special

K132807 - MONITORING STATION, CONNEX(R) CENTRAL STATION (CS)

K132807 is an FDA 510(k) clearance for MONITORING STATION, manufactured by Welch Allyn, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Special 510(k) pathway after a 144-day FDA review.

K132807 · Welch Allyn, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2014
Decision
144d
Days
Class 2
Risk

K132807 is an FDA 510(k) clearance for the MONITORING STATION, CONNEX(R) CENTRAL STATION (CS). Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Skaneateles Falls, US). The FDA issued a Cleared decision on January 31, 2014 after a review of 144 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K132807

510(k) Number K132807 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2013
Decision Date January 31, 2014
Days to Decision 144 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 125d · This submission: 144d
Pathway characteristics
Modification to existing cleared device.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 308
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K132807.
A SERIES AND Q SERIES PATIENT MONITORS
K131898 · Guangdong Biolight Meditech Co., Ltd. · Feb 2014
AIRSTRIP REMOTE PATIENT MONITORING
K133450 · Airstrip Technologies, LP · Feb 2014
AIRSTRIP REMOTE PATIENT MONITORING
K133394 · Airstrip Technologies, LP · Feb 2014
VISI MOBILE MONITIORING SYSTEM
K133586 · Sotera Wireless, Inc. · Dec 2013
MCKESSON CARDIOLOGY HEMO
K131497 · Mckesson Israel , Ltd. · Dec 2013
BM3/BM3 PLUS
K132033 · Noblitt & Rueland · Dec 2013
K132807 · MONITORING STATION, CONNEX(R) CENTRAL STATION (CS)
Download PDF FDA Summary Welch Allyn, Inc.